Reyataz 200 mg · CNK 2208593

Product information

Reyataz 200 mg
180 (3 x 60)
2208593
0 / 10
Locked

Product properties

J05AE08
Bristol-Myers Squibb Pharma
Capsule, hard
EU/1/03/267/011
M42
Public
494142-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Unknown reason) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

No status history available.

Composition

1 ingredient

Substance Type Strength CAS
Active ingredient
229975-97-7

Additional information

View on BCPI

Availability statistics

Unknown
0 days
0
0